drugset / Trial / NCT05183243
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
NaSingle-groupOpen-labelTreatment
Summary
Evaluate the safety and tolerability of GH21 in patients with advanced solid tumors. Estimate the maximum tolerated dose (MTD) in patients with advanced solid tumors.
Timeline
- Start
- 2022-02-20
- Primary completion
- 2024-12-31
- Completion
- 2025-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GH21 | Unknown | — | Oral |